Orsay, France-based Imagine Eyes landed CE Mark approval to market its rtx1 retinal camera, a device designed to image the retina at the cellular scale, which help clinicians observe the micro vascular structures that are frequently affected by vision-degrading diseases.
The newly approved rtx1 retinal camera, which is focused at the retina’s cone photoreceptor layer to avoid image blurring, is the 1st adaptive optics platform system approved for clinical use, the company said.
